Recognition of Self Class IU Major Histocompatibility Complex Antigens by cd8+ T Cell Clones Derived from Rheumatoid Arthritis Synovial Membrane

References

• Zvaifier N. The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol 1973; 16: 265–336
   PubMedGoogle Scholar
• Kobayashi I, Ziff M. Electron microscopic studies of lymphoid cells in the rheumatoid synovial membrane. Arthritis Rheum 1973; 16: 471–486
   PubMedGoogle Scholar
• Meijer C LM, Graaff-Reitsma C B, Lafeber G JM, Cats A. In situ localisation of lymphocyte subsets in synovial membranes of patients with rheumatoid arthritis with monclonal antibodies. J Rheumatol 1982; 9: 359–365
   PubMed Web of Science ®Google Scholar
• Klareskog L, Forsum U, Wigren A, Wigzell H. Relationships between HLA-DR-expressing cells and T lymphocytes of different subsets in rheumatoid synovial tissue. Scand J Immunol 1982; 15: 501–507
   Web of Science ®Google Scholar
• Young C L, Adamson T C, Vaughan J H, Fox R I. Immunologic characterisation of synovial membrane lymphocytes in rheumatoid arthritis. Arthritis Rheum 1984; 27: 32–39
   PubMed Web of Science ®Google Scholar
• Malone D G, Wahl S M, Tsokos M, Catell H, Decker J L, Wilder R L. Immune function in severe, active rheumatoid arthritis. J Clin Invest 1984; 74: 1173–1185
   PubMed Web of Science ®Google Scholar
• Janossy G, Duke O, Poulter L W, Panayi G, Bofill M, Goldstein G. Rheumatoid arthritis: a disease of T lyphocyte/ macrophage immunoregulatin. Lancet 1981; ii: 849–842
   Google Scholar
• Meuer S C, Scholossman S F, Reinherz E L. Clonal analysis of human cytotoxic T cells: T4+ and T8+ effector cells recognise products of different major histocompatibility complex regions. Proc Natl Acad Sci (USA) 1982; 79: 4395–4399
   PubMed Web of Science ®Google Scholar
• Krensky A M, Reiss C R, Mier J M, Strominger J R, Burakoff S J. Long-term human cytolytic T cell lines allospeciflc for HLA-DR6 antigen are OKT4 +. Proc Natl Acad Sci (USA) 1982; 79: 2365–2369
   PubMed Web of Science ®Google Scholar
• Iguchi T, Ziff M. Electron microscopic study of rheumatoid synovial vasculature. J Clin Invest 1986; 77: 355–361
   PubMed Web of Science ®Google Scholar
• Amento E P, Kurnick J T, Epstein A, Krane S M. Modulation of synovial cell products by a factor from a human cell line: T lymphocyte induction of a mononuclear cell factor. Proc Natl Acad Sci (USA) 1982; 79: 5307–5311
   PubMedGoogle Scholar
• Dayer J M, Robinson D R, Krane S M. Prostaglandin production by rheumatoid synovial cells: stimulation by a factor from human mononuclear cells. J Exp Med 1977; 145: 1399–1404
   PubMed Web of Science ®Google Scholar
• Gaston J SH, Strober S, Solvera J J, Gandour D, Lane N, Schurman D, Hoppe R T, Chin R C, Eugui E M, Vaughan J H, Allison A C. Dissection of the mechanisms of immune injury in rheumatoid arthritis using total lymphoid irradiation. Arthritis Rheum 1988; 31: 21–30
   PubMedGoogle Scholar
• Mizel S B, Dayer J M, Krane S M, Mergenhagen S E. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin-1). Proc Natl Acad Sci (USA) 1980; 78: 2474–2477
   Google Scholar
• Taylor-Upsahl M R, Abrahamsen T G, Natvig J B. Rheumatoid factor plaque-forming cells in rheumatoid synvoial tissue. Clin Exp Immunol 1977; 28: 197–203
   PubMedGoogle Scholar
• Burmester G R, Yu D TY, Irani A -M, Kunkel H G, Winchester R J. Ia+ T cells in synovial fluid and tissues of patients with rheumatoid arthritis. Arthritis Rheum 1981; 24: 1370–1376
   PubMed Web of Science ®Google Scholar
• Romain P L, Schlossman S F. Human T lymphocyte subsets. Functional heterogeneity and surface recognition structures. J Clin Invest 1984; 74: 1559–1565
   PubMedGoogle Scholar
• Ropes M W, Bennett G A, Cobb S, Jacox R, Jesser R A. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175–176
   PubMedGoogle Scholar
• Strober S, Tanay A, Field E, Hoppe R T, Calin A, Engleman E, Kotzin B, Brown B W, Kaplan H S. Effect of total lymphoid irradiation in intractable rheumatoid arthritis. Ann Int Med 1985; 102: 441–149
   PubMed Web of Science ®Google Scholar
• Rickinson A B., Rowe M, Hart I, Yao Q Y, Henderson L E, Rabin H, Epstein M A. T-cell-mediated regression of “spontaneous” and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A. Cell Immunol 1984; 87: 646–664
   PubMed Web of Science ®Google Scholar
• Rosenberg S A, Grimm E A, McGrogan M, Doyle M, Kawasaki E, Koths K, Mark D F. Biological activity of recombinant interleukin-2 produced in Escherichia coli. Science 1984; 223: 1412–1415
   PubMed Web of Science ®Google Scholar
• Gaston J SH, Bacon P A, Strober S. Enchancement of T lymphocyte growth by human transferrin in the presence of fetal bovine serum. Cell Immunol 1987; 106: 366–375
   PubMedGoogle Scholar
• Field E, Engleman E G, Terrell C P, Strober S. Reduced in vitro immune responses of purified human Leu-3 (helper/inducer phenotype) cells after total lymphoid irradiation. J Immunol 1984; 132: 1031–1034
   PubMedGoogle Scholar
• Gaston J SH, Rickinson A B. Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. J Exp Med 1983; 158: 280–293
   PubMedGoogle Scholar
• Romain P L, Schlossman S F. Human T lyphocyte subsets. Functional heterogeneity and surface recognition structures. J Clin Invest 1984; 74: 1559–1565
   PubMedGoogle Scholar
• Swain S L. Significance of Lyt 2 phenotypes: Lyt-2 antibodies block activities of T cells that recognize class I major histocompatibility complex antigens regardless of their function. Proc Natl Acad Sci (USA) 1981; 78: 7101–7105
   PubMed Web of Science ®Google Scholar
• Swain S L. T cell subsets and the recognition of MHC class. Immunnol Rev 1983; 74: 129–142
   PubMed Web of Science ®Google Scholar
• Doyle C, Strominger J L. Interaction between CD4 and Class II MHC Molecules mediates cell adhesion. Nature 1987; 330: 256–258
   PubMed Web of Science ®Google Scholar
• Norment A M, Salter R D, Parham P, Englehard V H, Littman D R. Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 1988; 336: 78–81
   Google Scholar
• MacDonald H R, Glasebrook A L, Bron C, Kelso A, Cerottini J C. Clonal heterogeneity in the functional requirement for Lyt2/3 molecules on cytolytic T lymphocytes (CTL): possible implications for the affinity of CTL antigen receptors. Immunol Rev 1982; 68: 89–115
   PubMedGoogle Scholar
• Marrack P, Enders R, Shimonkevitz R, Zlotnik A, Dialynas D, Fitch F, Kappler J. The major histocompatibility complex-restricted antigen receptor in T cells. Role of the L3T4 product. J Exp Med 1983; 158: 1077–1091
   PubMed Web of Science ®Google Scholar
• Dembic Z, Haas W, Zamoyska R, Parnes J, Steinmetz M, von Boehmer H. Transfection of the CD8 gene enhances T-cell recognition. Nature 1987; 326: 510–511
   PubMed Web of Science ®Google Scholar
• Flomenberg N, Naito K, Duffy E, Knowles R W, Evans R L, Dupont B. Allocytotoxic T cell clones; both Leu 2 - 3 - and Leu 2-3+ T cells recognize class I histocompatibility antigens. Eur J Immunol 1983; 13: 905–911
   PubMedGoogle Scholar
• Haas W, von Boehmer H. Surface markers of cytotoxic T lymphocyte clones. Euro J Immunol 1984; 14: 383–384
   PubMedGoogle Scholar
• Greenstein J L, Kappler J, Marrack P, Burakoff S J. The role of L3T4 in the recognition of la by a cytotoxic, H-2Dd-specific T cell hybridoma. J Exp Med 1984; 159: 1213–1224
   PubMedGoogle Scholar
• Greenstein J L, Malissen B, Burakoff S J. Role of L3T4 in antigen driven activation of a class I-specific T cell hybridoma. J Exp Med 1985; 162: 369–374
   PubMed Web of Science ®Google Scholar
• Golding H, Singer A. Specificity, phenotype, and precursor frequency of primary cytololytic T lymphocytes specific for class II major histocompatibility antigens. J Immunol 1985; 1610–1615
   PubMedGoogle Scholar
• Macphail S, Stutman O. L3T4+ cytotoxic T lymphocytes specific for class I H-2 antigens are activated in primary mixed lymphcyte reactions. J Immunol 1987; 139: 4007–4015
   PubMedGoogle Scholar
• Saizawa K, Rojo J, Janeaway C A. Evidence for a physical association of CD4 and the CD3:αβ T cell receptor. Nature 1987; 328: 260–263
   PubMed Web of Science ®Google Scholar
• Emmrich F, Strittmatter U, Eichmann K. Synergism in the activation of human T cell by cross-linking the T-cell receptor complex with the CD8 differentiation antigen. Proc Natl Acad Sci (USA) 1986; 83: 8298–8302
   PubMedGoogle Scholar
• Buchan G, Barret K, Fujita T, Taniguchi T, Maini R N, Feldmann M. Detection of activated T cell products in the rheumatoid joint using cDNA proes to interluekin-2 (IL2) receptor and interferon gamma. Clin Exp Immunol, (in press)
   Google Scholar
• Bich-Thung L T, Lane H C, Fauci A S. Recombinant inter-leukin-2 induced polyclonal proliferation of in vitro unstimulated human peripheral blood lymphocytes. Cell Immunol 1986; 98: 396–410
   PubMedGoogle Scholar
• Kehrl J H, Dukovich M, Whalen G, Katz P, Fauci A S, Greene W C. Novel interleukin-2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells. J Clin Invest 1988; 81: 200–205
   PubMed Web of Science ®Google Scholar
• Goto M, Zvaifler N J. Characterization of the natural killerlike lymphocytes in rheumatoid synovial fluid. J Immunol 1985; 134: 1483–1486
   PubMed Web of Science ®Google Scholar
• Lanzavecchia A. Antigen specific interaction between T and B cells. Nature 1985; 314: 537–539
   PubMed Web of Science ®Google Scholar
• Wallace L E, Rowe M, Gaston J SH, Rickinson A B, Epstein M A. Cytotoxic T cell recognition of Epstein-Barr virus-infection B cells. Ill establishment of HLA-restricted cytotoxic T cell lines using interleukin 2. Eur J Immunol 1982; 12: 1012–1018
   PubMed Web of Science ®Google Scholar
• Huber C, Merckenschlager M, Gattringer M, Royston I, Fink U, Braunsteiner H. Human autologous mixed lymphocyte reactivity is primarily specific for xenoprotein determinants absorbed by antigen-presenting cells during rosette formation with sheep erythrocytes. J Exp Med 1982; 155: 1222–1227
   PubMedGoogle Scholar
• Takeuchi T, Rudd C E, Schlossman S F, Morimoto C. Induction of suppression following autologous mixed lymphocyte reaction; role of a novel 2H4 antigen. Eur J Innunol 1987; 17: 97–103
   PubMedGoogle Scholar
• Romain P L, Schlossman S F, Reinherz E L. Surface molecules involved in self-recognition and T cell activation in the autologous mixed lymphocyte reaction. J Immunol 1984; 133: 1093–1100
   PubMedGoogle Scholar
• Smolen J S, Luger A T, Chused T M, Steinberg A D. Responder cells in the human autologous mixed lymphocyte reaction. J Clin Invest 1981; 68: 1601–1604
   PubMed Web of Science ®Google Scholar
• Benussan A, Meuer S C, Schlossman S F, Reinherz E L. Delineation of a immunorgeulatory amplifier population recognizing autologous la molecules. Analysis with human T cell clones. J Exp Med 1985; 159: 559–576
   Google Scholar
• Zauderer M. Origin and specificity of autoreactive T cells. Adv Immunol 1989; 45: 417–437
   PubMedGoogle Scholar
• Hausmann P B, Stobo J D. Specificity and function of human autologous reactive T cells. J Exp Med 1979; 149: 1537–1542
   PubMedGoogle Scholar
• Glimcher L H, Longo D L, Green I, Schwartz R H. Murine sygeneic mixed lymphocyte response. Target antigens are self la molecules. J Exp Med 1981; 154: 1632–1670
   Google Scholar
• Glimcher L H, Shevach E. Production of autoreactive I region-restricted T cell hybridomas. J Exp Med 1982; 156: 640–645
   PubMed Web of Science ®Google Scholar
• Finnegan A, Needleman B, Hodes R J. Activation of B cells by autoreactive T cells: cloned autoreactive T cells activate B cells by two distinct pathways. J Innunol 1984; 133: 78–85
   Google Scholar
• Dos Reiss G A, Shevach E M. Analysis of autoreactive I region- restricted T cell colonies isolated from the guinea pig syngeneic mixed leukocyte reaction and from immune responses to conventional foreign antigens. Eur J Immunol 1985; 15: 466–472
   PubMedGoogle Scholar
• Faherty D A, Johnson D R, Zauderer M. Origin and specificity of autoreactive T cells in antigen-induced proliferation. J Exp Med 1985; 161: 1293–1301
   PubMed Web of Science ®Google Scholar
• Kotani H, Mitsuya H, Jarrett R F, Yenokida G G, James S P, Strober W. An autoreactive T cell clone that can be activated to provide both help and suppressor function. J Immunol 1986; 136: 1951–1959
   PubMed Web of Science ®Google Scholar
• Shiohara T, Ruddle N H, Horowitz M, Moellmann G E, Lerner A B. Anti-tumor activity of class II MHC antigen-restricted cloned autoreactive T cells. J Immunol 1987; 138: 1971–1978
   PubMedGoogle Scholar
• Teyton L, Lotteau V, Turmel P, Arenzana-Seisdedos F, Virelizier J -L, Pujol J -P, Loyau G, Piatier-Tonneau D, Auffray C, Charron D J. HLA DR, DQ, and DP antigen expression in rheumatoid synovial cells: a biochemical and quantitative study. J Immunol 1987; 138: 1730–1738
   PubMed Web of Science ®Google Scholar
• Kirby J A, Pepper J R, Reader J A, Corbishley C M, Hudson L. Precursor frequency of donor-specific lymphocytes recovered from canine lung transplants. Clin Exp Immunol 1986; 63: 334–342
   PubMedGoogle Scholar
• Orocz C G, Zinn N E, Sirineh L P, Ferguson R M. Size of the donor reactive CT1 pool determined by limiting dilution analysis is sponge matrix allografts. Transplantation 1986; 41: 400–404, 64
   PubMedGoogle Scholar
• Sedgwick J, Brostoff S, Mason D. Experimental allergic encephalomyelitis in the absence of a classical delayed type hyper-senitivity reaction. J Exp Med 1987; 165: 1058–1075
   PubMed Web of Science ®Google Scholar